James Basta, J.D.

James Basta, J.D.

Executive Vice President, General Counsel and Corporate SecretaryatIntellia Therapeutics· In proxies 2021–2025

Pay in FY2025-62% from the year before · Intellia Therapeutics stock -22.9% the same year

James Basta, J.D. was paid $1.8M in FY2025 (Dec), down 62%. Intellia Therapeutics stock fell 22.9% that year.

Pay$100 in the stock at the end of FY20 → $17
Pay is from the Summary Compensation Table of each Intellia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Intellia TherapeuticsPublic company · 5 yr
    • Executive Vice President, General Counsel and Corporate Secretary2021 – Present · 5 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?